Global autoimmune disease diagnostics market will reach $10.81 billion by 2031, growing by 8.1% annually over 2021-2031, driven by the growing prevalence of autoimmune diseases, the strong investment in research and development activities, the rise in technological advancements, increasing patient awareness and healthcare expenditure, and favorable government policies.
Highlighted with 87 tables and 103 figures, this 188-page report “Global Autoimmune Disease Diagnostics Market 2021-2031 by Product (Assay Kits & Consumables, Analyzers & Instruments), Test Type (Autoantibodies and Immunologic, Inflammatory Marker, Routine Laboratory, Others), Disease Type (Systemic, Localized), Gender (Female, Male), Age (<44, 44-64, >64), End User (Hospitals, Clinics, Diagnostic Labs), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global autoimmune disease diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global autoimmune disease diagnostics market in every aspect of the classification from perspectives of Product, Test Type, Disease Type, Gender, Age, End User, and Region.
Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Assay Kits & Consumables
• Analyzers & Instruments
Based on Test Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Autoantibodies and Immunologic Tests
o Antinuclear Antibody Tests
o Anti-cyclic Citrullinated Peptide
o Enzyme-Linked Immunosorbent Assay (ELISA)
o Rheumatoid Factor
o Thyroid Antibody Tests
o Other Autoantibodies and Immunologic Tests
• Inflammatory Marker Tests
o C-Reactive Protein (CRP)
o Erythrocyte Sedimentation Rate (ESR)
o Other Inflammatory Marker Tests
• Routine Laboratory Tests
o Urinalysis
o Complete Blood Count (CBC) Tests
o Other Routine Laboratory Tests
• Other Test Types
Based on Disease Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Systemic Autoimmune Disease
o Rheumatoid Arthritis
o Systemic Lupus Erythematosus (SLE)
o Psoriasis/Psoriatic Arthritis
o Other Systemic Autoimmune Diseases
• Localized Autoimmune Disease
o Thyroiditis
o Multiple Sclerosis
o Inflammatory Bowel Disease
o Type 1 Diabetes
o Other Localized Autoimmune Diseases
Based on Gender, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Female Patients
• Male Patients
Based on Age, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• < 44
• 44 - 64
• > 64
Based on End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospitals
• Clinics
• Diagnostic Labs
• Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, Other Nations)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Product, Disease Type, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories
Beckman Coulter, Inc.
Biomerieux SA
Bio-rad Laboratories Inc.
F. Hoffmann-la Roche Ltd.
Hemagen Diagnostics Inc.
Myriad Genetics Inc.
PerkinElmer Inc. (Euroimmun AG)
Quest Diagnostics Inc.
Siemens Healthineers Inc.
Thermo Fisher Scientific Inc.
Trinity Biotech PLC
Werfen Company (Inova Diagnostics Inc.)
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 11
1.1 Industry Definition and Research Scope 11
1.1.1 Industry Definition 11
1.1.2 Research Scope 12
1.2 Research Methodology 15
1.2.1 Overview of Market Research Methodology 15
1.2.2 Market Assumption 16
1.2.3 Secondary Data 16
1.2.4 Primary Data 16
1.2.5 Data Filtration and Model Design 17
1.2.6 Market Size/Share Estimation 18
1.2.7 Research Limitations 19
1.3 Executive Summary 20
2 Market Overview and Dynamics 23
2.1 Market Size and Forecast 23
2.1.1 Impact of COVID-19 on World Economy 24
2.1.2 Impact of COVID-19 on the Market 26
2.2 Major Growth Drivers 28
2.3 Market Restraints and Challenges 33
2.4 Emerging Opportunities and Market Trends 36
2.5 Porter’s Fiver Forces Analysis 40
3 Segmentation of Global Market by Product 45
3.1 Market Overview by Product 45
3.2 Assay Kits & Consumables 47
3.3 Analyzers & Instruments 48
4 Segmentation of Global Market by Test Type 49
4.1 Market Overview by Test Type 49
4.2 Autoantibodies and Immunologic Tests 51
4.2.1 Antinuclear Antibody Tests 53
4.2.2 Anti-cyclic Citrullinated Peptide 54
4.2.3 Enzyme-Linked Immunosorbent Assay (ELISA) 55
4.2.4 Rheumatoid Factor 56
4.2.5 Thyroid Antibody Tests 57
4.2.6 Other Autoantibodies and Immunologic Tests 58
4.3 Inflammatory Marker Tests 59
4.3.1 C-Reactive Protein (CRP) 61
4.3.2 Erythrocyte Sedimentation Rate (ESR) 62
4.3.3 Other Inflammatory Marker Tests 63
4.4 Routine Laboratory Tests 64
4.4.1 Urinalysis 66
4.4.2 Complete Blood Count (CBC) Tests 67
4.4.3 Other Routine Laboratory Tests 68
4.5 Other Test Types 69
5 Segmentation of Global Market by Disease Type 70
5.1 Market Overview by Disease Type 70
5.2 Systemic Autoimmune Disease 72
5.2.1 Rheumatoid Arthritis 74
5.2.2 Systemic Lupus Erythematosus (SLE) 75
5.2.3 Psoriasis/Psoriatic Arthritis 76
5.2.4 Other Systemic Autoimmune Diseases 77
5.3 Localized Autoimmune Disease 78
5.3.1 Thyroiditis 80
5.3.2 Multiple Sclerosis 81
5.3.3 Inflammatory Bowel Disease 82
5.3.4 Type 1 Diabetes 83
5.3.5 Other Localized Autoimmune Diseases 84
6 Segmentation of Global Market by Gender 85
6.1 Market Overview by Gender 85
6.2 Female Patients 87
6.3 Male Patients 88
7 Segmentation of Global Market by Age 89
7.1 Market Overview by Age 89
7.2 < 44 91
7.3 44 - 64 92
7.4 > 64 93
8 Segmentation of Global Market by End User 94
8.1 Market Overview by End User 94
8.2 Hospitals 96
8.3 Clinics 97
8.4 Diagnostic Labs 98
8.5 Other End Users 99
9 Segmentation of Global Market by Region 100
9.1 Geographic Market Overview 2021-2031 100
9.2 North America Market 2021-2031 by Country 104
9.2.1 Overview of North America Market 104
9.2.2 U.S. 108
9.2.3 Canada 111
9.2.4 Mexico 113
9.3 European Market 2021-2031 by Country 115
9.3.1 Overview of European Market 115
9.3.2 Germany 119
9.3.3 U.K. 121
9.3.4 France 123
9.3.5 Spain 125
9.3.6 Italy 127
9.3.7 Russia 129
9.3.8 Rest of European Market 131
9.4 Asia-Pacific Market 2021-2031 by Country 133
9.4.1 Overview of Asia-Pacific Market 133
9.4.2 Japan 137
9.4.3 China 140
9.4.4 Australia 142
9.4.5 India 144
9.4.6 South Korea 146
9.4.7 Rest of APAC Region 148
9.5 South America Market 2021-2031 by Country 150
9.5.1 Argentina 153
9.5.2 Brazil 155
9.5.3 Chile 157
9.5.4 Rest of South America Market 159
9.6 MEA Market 2021-2031 by Country 160
9.6.1 UAE 163
9.6.2 Saudi Arabia 165
9.6.3 South Africa 167
9.6.4 Other National Markets 169
10 Competitive Landscape 170
10.1 Overview of Key Vendors 170
10.2 New Product Launch, Partnership, Investment, and M&A 173
10.3 Company Profiles 174
Abbott Laboratories 174
Beckman Coulter, Inc. 176
Biomerieux SA 177
Bio-rad Laboratories Inc. 178
F. Hoffmann-la Roche Ltd. 179
Hemagen Diagnostics Inc. 180
Myriad Genetics Inc. 181
PerkinElmer Inc. (Euroimmun AG) 182
Quest Diagnostics Inc. 183
Siemens Healthineers Inc. 184
Thermo Fisher Scientific Inc. 185
Trinity Biotech PLC 186
Werfen Company (Inova Diagnostics Inc.) 187
RELATED REPORTS 188
List of Tables:
Table 1. Snapshot of Global Autoimmune Disease Diagnostics Market in Balanced Perspective, 2021-2031 21
Table 2. World Economic Outlook, 2021-2031 25
Table 3. World Health Spending by Region, $ bn, 2013-2020 32
Table 4. Main Product Trends and Market Opportunities in Global Autoimmune Disease Diagnostics Market 36
Table 5. Global Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 45
Table 6. Global Autoimmune Disease Diagnostics Market by Test Type, 2021-2031, $ mn 49
Table 7. Global Autoimmune Disease Diagnostics Market: Autoantibodies and Immunologic Tests by Type, 2021-2031, $ mn 52
Table 8. Global Autoimmune Disease Diagnostics Market: Inflammatory Marker Tests by Type, 2021-2031, $ mn 60
Table 9. Global Autoimmune Disease Diagnostics Market: Routine Laboratory Tests by Type, 2021-2031, $ mn 65
Table 10. Global Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 70
Table 11. Global Autoimmune Disease Diagnostics Market: Systemic Autoimmune Disease by Type, 2021-2031, $ mn 73
Table 12. Global Autoimmune Disease Diagnostics Market: Localized Autoimmune Disease by Type, 2021-2031, $ mn 79
Table 13. Global Autoimmune Disease Diagnostics Market by Gender, 2021-2031, $ mn 85
Table 14. Global Autoimmune Disease Diagnostics Market by Age, 2021-2031, $ mn 89
Table 15. Global Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 94
Table 16. Global Autoimmune Disease Diagnostics Market by Region, 2021-2031, $ mn 101
Table 17. Leading National Autoimmune Disease Diagnostics Market, 2021 and 2031, $ mn 103
Table 18. North America Autoimmune Disease Diagnostics Market by Country, 2021-2031, $ mn 106
Table 19. U.S. Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 110
Table 20. U.S. Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 110
Table 21. U.S. Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 110
Table 22. Canada Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 112
Table 23. Canada Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 112
Table 24. Canada Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 112
Table 25. Mexico Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 114
Table 26. Mexico Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 114
Table 27. Mexico Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 114
Table 28. Europe Autoimmune Disease Diagnostics Market by Country, 2021-2031, $ mn 118
Table 29. Germany Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 120
Table 30. Germany Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 120
Table 31. Germany Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 120
Table 32. U.K. Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 122
Table 33. U.K. Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 122
Table 34. U.K. Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 122
Table 35. France Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 124
Table 36. France Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 124
Table 37. France Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 124
Table 38. Spain Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 126
Table 39. Spain Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 126
Table 40. Spain Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 126
Table 41. Italy Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 128
Table 42. Italy Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 128
Table 43. Italy Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 128
Table 44. Russia Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 130
Table 45. Russia Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 130
Table 46. Russia Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 130
Table 47. Autoimmune Disease Diagnostics Market in Rest of Europe by Country, 2021-2031, $ mn 132
Table 48. APAC Autoimmune Disease Diagnostics Market by Country, 2021-2031, $ mn 135
Table 49. Japan Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 139
Table 50. Japan Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 139
Table 51. Japan Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 139
Table 52. China Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 141
Table 53. China Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 141
Table 54. China Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 141
Table 55. Australia Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 143
Table 56. Australia Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 143
Table 57. Australia Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 143
Table 58. India Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 145
Table 59. India Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 145
Table 60. India Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 145
Table 61. South Korea Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 147
Table 62. South Korea Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 147
Table 63. South Korea Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 147
Table 64. Autoimmune Disease Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, $ mn 149
Table 65. South America Autoimmune Disease Diagnostics Market by Country, 2021-2031, $ mn 152
Table 66. Argentina Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 154
Table 67. Argentina Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 154
Table 68. Argentina Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 154
Table 69. Brazil Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 156
Table 70. Brazil Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 156
Table 71. Brazil Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 156
Table 72. Chile Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 158
Table 73. Chile Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 158
Table 74. Chile Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 158
Table 75. MEA Autoimmune Disease Diagnostics Market by Country, 2021-2031, $ mn 162
Table 76. UAE Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 164
Table 77. UAE Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 164
Table 78. UAE Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 164
Table 79. Saudi Arabia Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 166
Table 80. Saudi Arabia Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 166
Table 81. Saudi Arabia Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 166
Table 82. South Africa Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 168
Table 83. South Africa Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 168
Table 84. South Africa Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 168
Table 85. Abbott Laboratories: Company Snapshot 174
Table 86. Abbott Laboratories: Business Segmentation 175
Table 87. Abbott Laboratories: Product Portfolio 175
